Theagene Jean-Manasse 4
4 · MAIA Biotechnology, Inc. · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2025-06-30+20,380→ 20,380 totalExercise: $1.80From: 2025-06-30Exp: 2035-06-30→ Common Stock (20,380 underlying)
Footnotes (1)
- [F1]The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.